Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 358

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

Open access
Ackerman, Margaret E., Crispin, Max, Yu, Xiaojie, Baruah, Kavitha, Boesch, Austin W., Harvey, David J., Dugast, Anne-Sophie, Heizen, Erin L., Ercan, Altan, Choi, Ickwon, Streeck, Hendrik, Nigrovic, Peter A., Bailey-Kellogg, Chris, Scanlan, Chris, Alter, Galit·2013·Journal of Clinical Investigation

Abstract

While the induction of a neutralizing antibody response against HIV remains a daunting goal, data from both natural infection and vaccine-induced immune responses suggest that it may be possible to induce antibodies with enhanced Fc effector activity and improved antiviral control via vaccination. However, the specific features of naturally induced HIV-specific antibodies that allow for the potent recruitment of antiviral activity and the means by which these functions are regulated are poorly defined. Because antibody effector functions are critically dependent on antibody Fc domain glycosylation, we aimed to define the natural glycoforms associated with robust Fc-mediated antiviral activity. We demonstrate that spontaneous control of HIV and improved antiviral activity are associated with a dramatic shift in the global antibody-glycosylation profile toward agalactosylated glycoforms. HIV-specific antibodies exhibited an even greater frequency of agalactosylated, afucosylated, and asialylated glycans. These glycoforms were associated with enhanced Fc-mediated reduction of viral replication and enhanced Fc receptor binding and were consistent with transcriptional profiling of glycosyltransferases in peripheral B cells. These data suggest that B cell programs tune antibody glycosylation actively in an antigen-specific manner, potentially contributing to antiviral control during HIV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci65708

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 4

  1. 10.1128/JVI.00313-11 · doi:10.1128/jvi.00313-11
  2. Strohmeier, 1995, J Leukoc Biol., 58, 403, 10.1002/jlb.58.4.403 · doi:10.1002/jlb.58.4.403
  3. Shaw, 1980, J Immunol., 125, 501, 10.4049/jimmunol.125.2.501 · doi:10.4049/jimmunol.125.2.501
  4. 10.1086/314988 · doi:10.1086/314988

Cited by

See all 358

Metadata

Authors
Ackerman, M. E., Crispin, M., Yu, X., Baruah, K., Boesch, A. W., Harvey, D. J., Dugast, A.-S., Heizen, E. L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P. A., Bailey-Kellogg, C., Scanlan, C., & Alter, G.
Venue
Journal of Clinical Investigation
Published
2013-04-08
Volume
123
Issue
5
Pages
2183-2192
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2172224306
Cited by
358
References
38
FWCI
13.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. https://app.cochat.ai/papers/10.1172/jci65708
The paper
Ackerman, M. E., Crispin, M., Yu, X., Baruah, K., Boesch, A. W., Harvey, D. J., Dugast, A.-S., Heizen, E. L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P. A., Bailey-Kellogg, C., Scanlan, C., & Alter, G. (2013). Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. Journal of Clinical Investigation. https://doi.org/10.1172/jci65708

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.